TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01617213

Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.
“Study is no longer needed as recent data have answered the primary hypotheses for this study.”

The sponsor’s own words in the registry.

Life of this trial

20122013201420152016Started2012-04Registered2012-06-08Primary completion2015-04

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
University of Virginia
Sponsor type
University, hospital or other
Conditions
Multiple Myeloma
Interventions
Melphalan; Lenalidomide
Participants
1
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.